NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P102. A total of 2 filers reported holding NOVABAY PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $273,000 | -55.2% | 973,683 | -1.0% | 0.00% | – |
| Q2 2015 | $610,000 | +4.3% | 983,208 | +16.0% | 0.00% | – |
| Q1 2015 | $585,000 | +10.2% | 847,752 | +0.6% | 0.00% | – |
| Q4 2014 | $531,000 | -24.7% | 842,652 | +0.3% | 0.00% | – |
| Q3 2014 | $705,000 | +13.0% | 839,762 | +6.2% | 0.00% | – |
| Q2 2014 | $624,000 | -28.2% | 790,383 | +6.4% | 0.00% | – |
| Q1 2014 | $869,000 | -1.6% | 742,863 | +3.5% | 0.00% | – |
| Q4 2013 | $883,000 | +15.4% | 717,563 | +60.3% | 0.00% | – |
| Q3 2013 | $765,000 | +61.7% | 447,603 | +30.6% | 0.00% | – |
| Q2 2013 | $473,000 | – | 342,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GARRISON BRADFORD & ASSOCIATES INC | 138,000 | $170,000 | 0.16% |
| BUCKINGHAM STRATEGIC WEALTH, LLC | 56,583 | $70,000 | 0.03% |
| EXENCIAL WEALTH ADVISORS, LLC | 59,679 | $71,000 | 0.03% |
| Orbitronix, LP | 25,100 | $31,000 | 0.02% |
| DRW Securities, LLC | 183,988 | $226,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 121,500 | $149,000 | 0.01% |
| EP Wealth Advisors, LLC | 13,267 | $16,000 | 0.00% |
| GLENMEDE TRUST CO NA | 300,000 | $369,000 | 0.00% |
| KCM INVESTMENT ADVISORS LLC | 23,333 | $29,000 | 0.00% |
| BOSTON FAMILY OFFICE LLC | 17,500 | $22,000 | 0.00% |